Concerning serum immunological data, it was noteworthy that we also found a lower level of circulating IgG in the anti-GBM group compared with the other two groups (p < 0.05, anti-GBM vs. MPO-AAV; p < 0.05, anti-GBM vs. DPPs). The gene discussed is MPO; the disease is glioblastoma.